Global Digital PCR (dPCR) and qPCR Market is Estimated to Grow at a CAGR of 7.8%

Date: 2015-08-19

“The global digital PCR (dPCR) and qPCR market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the digital PCR (dPCR) and qPCR market, the Asia-Pacific region is expected to grow at the highest CAGR of ~10.7% in the forecast period. The growth of the digital PCR (dPCR) and qPCR market is driven by factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases and genetic disorders, and increased public-private investments, funds, and grants. However, factors such as high cost of dPCR instruments and limitations of qPCR and dPCR techniques are restraining the growth of this market. Attempts for adoption, implementation of MIQE guidelines for publishing qPCR and dPCR-based research is posing a significant challenge for the growth of the digital PCR (dPCR) and qPCR market.   

In this report, the global digital PCR (dPCR) and qPCR market has been segmented on the basis of type of technology (real-time PCR and digital PCR), type of product (instruments, reagents and consumables, and softwares and services), type of end-users (research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories) applications and type of application (research, clinical, and forensic applications). The real-time PCR (qPCR) technology market accounted for the largest share of the global digital PCR (dPCR) and qPCR market in 2014, followed by the digital PCR (dPCR) market. Factors such as technological advancements in the field of qPCR, rising adoption of qPCR in research and medical diagnosis, benefits offered by robotics in lab automation, and increasing installation base of qPCR instruments are driving the growth of qPCR technology market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of 39.7% of the global digital PCR (dPCR) and qPCR market in 2014, followed by Europe. The digital PCR (dPCR) and qPCR market in the North America is primarily driven by factors such as increase in public and private funding for development of qPCR and dPCR technology, growing number of cancer patients, continuous reduction in average cost of gene sequencing, and presence of major pharmaceutical companies in the U.S. However, financial constraints faced by market players are limiting the growth of the digital PCR (dPCR) and qPCR market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 10.7% in the next five years, owing to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market, and strengthening cancer research in Japan.

The global digital PCR (dPCR) and qPCR market is highly competitive with a large number of global as well as local market players. As of 2013, the global digital PCR (dPCR) and qPCR market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), and F. Hoffmann-La Roche, Ltd. (Switzerland), which together accounted for ~70% of the market. New product launches, product enhancements, and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the global digital PCR (dPCR) and qPCR market.    

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample